NEWS
May 21, 2026

SSRP Institute Welcomes GuardianMD as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [May 21, 2026] — The SSRP Institute announces that GuardianMD has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process.

GuardianMD is a healthcare services organization focused on physician collaboration and medical direction. It also provides telemedicine clearance services for healthcare practices. The company supports clinics with compliance-related processes and oversight structure. GuardianMD’s model includes operational infrastructure intended to support both practices and collaborating physicians. Its work is centered on helping these relationships function within applicable regulatory requirements.

As the nominating SSRP Member, Darren Frank, CEO of Infusive said: “GuardianMD is helping redefine what compliant growth can look like within the wellness and optimization space. Their physician network, operational infrastructure, and compliance-first approach give clinics the foundation needed to scale responsibly while prioritizing patient safety and quality care. At Infusive, when we see a clinic partnered with GuardianMD, we know they’re serious about compliance and quality oversight, and that matters. We’re excited to support the impact GuardianMD continues to make across the industry and within the SSRP community.”

For SSRP Members, this partnership adds a vetted resource in physician oversight and medical direction. It also offers support in areas related to compliance and practice structure. GuardianMD’s services align with the operational needs of practices navigating state-specific requirements. They also address documentation and collaboration workflows that may be part of day-to-day practice operations.

“SSRP has built an incredible community of clinicians who are passionate about advancing wellness medicine responsibly and ethically,” said Dr. Chris Seitz, Founder and CEO of GuardianMD. “As more nurses, nurse practitioners, and wellness providers enter this space, the need for compliant medical oversight and operational infrastructure becomes increasingly important. We’re proud to support SSRP members with physician collaboration, telemedicine clearance services, and scalable compliance solutions that allow practices to grow with confidence.”

Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice.

For more information and to view the GuardianMD Partner Page, visit:
SSRP GuardianMD Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
May 18, 2026
Ep. 088 - A Deeper Look at the RAAS System
Preview Only
Rabbit Holes – Episode 088

A Deeper Look at the RAAS System

Dr. Seeds uses this Rabbit Holes episode to build on Journal Club Episode 87, revisiting the renin-angiotensin-aldosterone system and its broader role in cellular signaling. The discussion focuses on receptor balance, local tissue effects, and the mechanisms linking RAS disruption to inflammation, fibrosis, and mitochondrial stress.(Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
William Seeds, MD May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
In this research article, I return to the subject of my first-ever Journal Club (Ep. 017), in which I discussed a 2023 research study entitled, “Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection” (2023) that examined a specific growth hormone-derived peptide to address the underlying immunological mechanisms of post-viral […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
May 11, 2026
Ep. 087 - The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Preview Only
Journal Club – Episode 087

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation

Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)

Preview Only — Become a member for full access
SSRP Institute May 6, 2026
Nutrition Education for Physicians and Medical Students
HEADLINE SCIENCE MAY 6, 2026 —Earlier in March, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Education announced an initiative to emphasize nutrition at the nation’s top medical schools. Reflecting U.S. Health and Human Services Secretary Robert Kennedy’s commitment to preventative medicine, this initiative will require “meaningful nutrition training” […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 4, 2026
Ep. 086 - May '26
Preview Only
SSRP Institute Apr 29, 2026
New ACC and AHA Cholesterol Management Guidelines
HEADLINE SCIENCE APRIL 29, 2026 – The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their cholesterol management guidelines, advocating for earlier and more aggressive intervention based on the understanding that cumulative lifetime exposure to high LDL-C drives atherosclerotic cardiovascular disease (ASCVD) risk. The guidelines aim to standardize care for dyslipidemia […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 27, 2026
Ep. 085 - Peptide Pharmacokinetics
Preview Only
Dissecting Protocols – Episode 085

Peptide Pharmacokinetics

Dissecting Protocols, Dr. Seeds breaks down the reasoning behind SubQ vs. IM peptide administration. From pharmacokinetic considerations to the growing misuse of combining peptides with oil-based medications in the same syringe, this discussion helps clarify proper application and safety considerations.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
William Seeds, MD Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084

The Cellular Impact of UVA vs. UVB Light (Part 2)

Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function

Catch Part 1 (Rabbit Holes – Ep. 081) HERE

Preview Only — Become a member for full access
SSRP Institute Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.